MARATTO

article · Frontiers in Pharmacology

Targeted liposomal nano-therapy combining anthocyanin and cisplatin reduces Ehrlich ascites carcinoma burden

20251 citationOpen accessKafr el-Sheikh University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Cis Ls and Ant Ls delivery strategy mitigates liver and kidney damage while enhancing anticancer efficacy against EAC.

Research topics

  • Curcumin's Biomedical Applications
  • Medicinal Plant Research
  • Flavonoids in Medical Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3389/fphar.2025.1659575

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.